Pulmonary infiltrates in the immunocompromised host

Israel Medical Association Journal

Volumn 5, Issue 2, 2003, Pages 112-115

  Maimon, Nimrod ^a   Almog, Yaniv ^a,b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Bronchoalveolar lavage; Bronchoscopy; Immunocompromised host; Open lung biopsy; Pulmonary infiltrates; Transbronchial biopsy

Indexed keywords

DIAGNOSIS; IMMUNOLOGY; PATIENT MONITORING; VENTILATION;

PULMONARY INFILTRATES;

PULMONARY DISEASES;

AMIODARONE; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BLEOMYCIN; BUSULFAN; CORTICOSTEROID DERIVATIVE; CYTARABINE; CYTOTOXIC AGENT; METHOTREXATE; NITROFURANTOIN; NITROSOUREA DERIVATIVE;

ARTIFICIAL VENTILATION; BACTERIAL INFECTION; BRONCHOSCOPY; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; DRUG INDUCED DISEASE; EMPIRICISM; ENDOTRACHEAL INTUBATION; FAT EMBOLISM; HEMATOLOGIC MALIGNANCY; HISTOLOGY; HUMAN; IMMUNE DEFICIENCY; LUNG ALVEOLUS PROTEINOSIS; LUNG DISEASE; LUNG FIBROSIS; LUNG HEMORRHAGE; LUNG INFECTION; LUNG INFILTRATE; LUNG INTERSTITIUM; LUNG LAVAGE; LUNG TOXICITY; LUNG VEIN OBSTRUCTION; MALIGNANT NEOPLASTIC DISEASE; MORBIDITY; NON INVASIVE MEASUREMENT; NONHUMAN; OPEN LUNG BIOPSY; OPPORTUNISTIC INFECTION; RADIATION PNEUMONIA; RECURRENT DISEASE; REVIEW; SURVIVAL; TRANSBRONCHIAL BIOPSY;

ANTI-BACTERIAL AGENTS; BRONCHOALVEOLAR LAVAGE; BRONCHOSCOPY; HUMANS; IMMUNOCOMPROMISED HOST; RESPIRATORY TRACT DISEASES;

EID: 0037302247     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Rosenow EC III, Wilson WR, Cockeril FR II. Pulmonary disease in the immunocompromised host. Mayo Clin Proc 1985;60:473-87.
2. Poe R, Gary W, Qazi R, Kallay M, Utell M, Morrow G. Predictors of mortality in the immunocompromised patients with pulmonary infiltrates. Arch Intern Med 1986;146:1304-8.
3. Rano A, Agusti C, Jimerenz P, et al. Pulmonary infiltrates in non-HIV immunocompromised patients: A diagnostic approach using non-invasive and bronchoscopic procedures. Thorax 2001;56:379-87.
4. Singer C, Armstrong D, Roser PP. Diffuse pulmonary infiltrates in immunosuppressed patients. Prospective study of 80 cases. Am J Med 1979;66:110-20.
5. Rao VK, Ritter J, Kollef MH. Utility of transbronchial biopsy in patients with acute respiratory failure - A postmortem study. Chest 1998;114:549-55.
6. Stover DE, Zaman MB, Hajdu SI. BAL in the diagnosis of diffuse pulmonary infiltrate in the immunosuppressed host. Ann Intern Med 1984;101:1-7.
7. Hohenadel IA, Kiworr M, Genitsariotis R, Zeidler D, Lorenz J. Role of BAL in immunocompromised patients treated with a broad-spectrum antibiotic and antifungal regimen. Thorax 2001;56:115-20.
8. Breuer R, Lossos IS, Lafair JS, Engelhard D. Utility of bronchoalveolar lavage in the assessment of diffuse pulmonary infiltrates in non-AIDS immunocompromised patients. Respir Med 1990;84:313-16.
9. Meduri GU, Stover DE, Greeno RA, Nash T, Zaman M. Bilateral bronchoalveolar lavage in the diagnosis of opportunistic pulmonary infections. Chest 1991;100:1272-7.
10. Griffiths MH, Koejan G, Miller RF, Godfrey-Faussett P. Diagnosis of pulmonary disease in HIV infection: Role of transbronchial biopsy and bronchoalveolar lavage. Thorax 1989;44:554-8.
11. Kramer MR, Berkman N, Mintz B, Godfrey S, Saute M, Amir G. The role of open lung biopsy in the management and outcome of patients with diffuse lung disease. Ann Thorac Surg 1998;65:198-202.
12. Papazian L, Pascal T, Bregeon F, et al. Open lung biopsy in patients with acute respiratory distress syndrome. Anesthesiology 1998;88:935-44.
13. Andersen HA. Transbronchial lung biopsies for diffuse pulmonary diseases: Results of 939 patients. Chest 1978;73:734-6.
14. Walker WA, Cole FH Jr, Khandekar A, Mahfood S, Watson D. Does open lung biopsy affect treatment in patients with diffuse pulmonary infiltrates? J Thorac Cardiovasc Surg 1989;97:534-40.
15. Havercos HW, Dowling JN, Pasculle AW, Myerowitz R, Lerberg D, Hakala T. Diagnosis of pneumonitis in immunocompromised patients by open lung biopsy. Cancer 1983;52:1093-7.
16. Staszewski H. Diffuse pulmonary infiltrates in immunocompromised patients. Postgrad Med 1993;94:69-74.
17. McPherson D, Buchalter SE. The role of bronchoalveolar lavage in patients considered for open lung biopsy. Clin Chest Med 1982;13:23-31.
18. White D, Wong P, Downey R. The utility of open lung biopsy in patients with hematologic malignancies. Am J Respir Crit Care Med 2000;161:723-9.
19. Robbins BE, Steiger Z, Wilson RF, et al. Diagnosis of acute diffuse pulmonary infiltrates in immunocompromised patients by open biopsy of the lung. Surg Gynecol Obstet 1992;175:8-12.
20. Wall CP, Gaensler EA, Carrington CB. Comparison of transbronchial and open biopsies in chronic infiltrative lung diseases. Am Rev Respir Dis 1981;123:280-5.
21. Leight GS Jr, Michaelis LL. Open lung biopsy for the diagnosis of acute, diffuse pulmonary infiltrates in the immunosuppressed patients. Chest 1978;73:477-82.
22. Fraire AE, Copper SP, Greenberg SD. Transbronchial lung biopsy. Histopathologic and morphometric assessment of diagnostic utility. Chest 1992;102:748-52.
23. Warner DO, Warner MA, Divertie MB. Open lung biopsy in patients with diffuse pulmonary infiltrate and respiratory failure. Am Rev Respir Dis 1998;137:90-4.
24. Bustmante CI, Wade JC. Treatment of interstitial pneumonia in cancer patients: Is empirical antibiotic therapy the answer? J Clin Oncol 1990;8:200-2.
25. Martin C, Papazian L, Payan MJ, Saux P, Gouin F. Pulmonary fibrosis correlates outcome in ARDS. A study in mechanically ventilated patients. Chest 1995;107:196-200.
26. Marquette CH, Copin MC, Wallet F, et al. Diagnostic tests for pneumonia in ventilated patients: Prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard. Am J Respir Crit Care Med 1995;151:1878-88.
27. Crawford SW. Noninfectious lung disease in the immunocompromised host. Respiration 1999;66:385-95.
28. Conces DJ Jr. Noninfectious lung disease in immunocompromised patients. J Thorac Imaging 1999;14:9-24.
29. Alam S, Chan KM. Noninfectious pulmonary complications after organ transplantation. Curr Opin Pulm Med 1996;2:412-18.
30. Ettinger NA, Trulock EP. Pulmonary considerations of organ transplantation. Am Rev Respir Dis 1991;144:433-51.
31. Gaensler EA, Carrington CB. Open biopsy for chronic infiltrative lung disease - Clinical roentgenographic and physiologic correlation in 502 patients. Ann Thorac Surg 1980;30:411-26.
32. Shah SS, Tsang V, Goldstraw P. Open lung biopsy - A safe reliable and accurate method for diagnosis in diffuse lung disease. Respiration 1992;59:243-6.
33. Gruson D, Hilbert G, Valentino R, et al. Utility of fiberoptic bronchoscopy in neutropenic patients admitted to the intensive care unit with pulmonary infiltrates. Crit Care Med 2000;28:2224-30.
34. Xaubet A, Torres A, Marco F. Pulmonary infiltrates in immunocompromised patients. Chest 1989;95:130-5.
35. Flabouris A, Myburgh J. The utility of open lung biopsy in patients requiring mechanical ventilation. Chest 1999;115:811-17.